Autism and Chiropractic



   Chiropractic adjustments shown to reverse autism in three-year old girl

A recent case study reported in the Annals of Vertebral Subluxation Research suggests that chiropractic adjustments can help reverse and prevent autism and issues related to the autism spectrum. The patient was an adopted three-year-old girl who was born at 28 weeks weighing 2 pounds, 5 ounces by a woman who had a history of prior drug abuse.

After two years of abnormal behavior and receiving multiple "autism" diagnoses from medical doctors, her parents decided to take her in for a thorough developmental evaluation. Five critical items were failed: social/emotional, communication, cognitive, adaptive/self-help and sensory.

The child's parents brought her to a local chiropractor, presenting with a cocktail of horrible symptoms including common neurological autism manifestations, unrelenting headaches, acid reflux, vomiting, sleeplessness and seizures. Subluxation-based specific chiropractic care was performed on the patient, which resulted in complete resolution of her headaches, acid reflux, vomiting and sleeplessness within one month. Significant improvements in autism-related issues were also noted, including calm behavior, increased eye contact, happier demeanor, improved attitude, increased focus and attention, and an initiation to sound out words. The study reports that the girl continues to progress as evidenced by a significantly increased vocabulary, continued improvement in attention and focus, and complete lack of epileptic episodes.


According to her mother, the patient from this case study has been "off all of her medications, she's making improvements with her occupational therapists, speech therapists, even her pre-school teachers are noticing a big difference. I'm getting my little girl back - look, she's making eye contact with me, and even starting to say a few words! She'll use her hands to do the motions to the Itsy Bitsy Spider song!" Her mother cannot stress enough the impact that chiropractic care has had on her daughter.

   Natural health experts speak out

According to Dr. Matthew McCoy, a chiropractor, public health researcher and editor of the journal that published the study, "If you damage or compress or otherwise interfere with the neurological structures in the spine this can have far reaching implications on the functioning of the body. Through research reports like this we are finding that correcting the misalignments or abnormal motion associated with these spinal problems reduces the nerve interference and people experience improvement."

The authors of the study stated, "We believe that working together, chiropractors, MDs, occupational therapists, and other health care provides will see results by managing the root cause(s) and not just the various symptoms presented by ASD children."

   Vertebral subluxation

"Finding the cause of autism, and not simply masking the symptoms, is the most effective way of managing the disease," one author of the study says. One such risk is thought to be spinal misalignments and/or abnormal motion of the spine, termed "vertebral subluxations" by chiropractors, which result in structural and neurological interference to the spine and nervous system. It is this interference that may cause a cascade of neuroendocrine events that lead to abnormal cholesterol metabolism. The theory is that, once those spinal distortions are corrected, the body is better able to balance its physiology.



Not surprisingly, other researchers have found similar results in regard to diseases in the autism spectrum being managed by chiropractic adjustments, and this case is one of several emerging studies describing this phenomena.



   Sources:

NaturalNews


Amalu WC. Autism, asthma, irritable bowel syndrome, strabismus and illness susceptibility: a case study in chiropractic management. Todays Chiropr 1998;27(5):32-47.

Marini NSC, Marini SC. Improvement in autism in a child coupled with reduction in vertebral subluxations; a case study and selective review of the literature: case report; review. J Pediatr Matern & Fam Health Chiropr 2010; 3:107-115.

Cleave J, Alcantara J, Holt K. Improvement in autistic behaviors following chiropractic care: a case series. J Pediatr Matern & Fam Health Chiropr 2011; 4:12-13.

Hoffman N, Russel D. Improvement in a 3 1/2-year-old autistic child following chiropractic intervention to reduce vertebral subluxation. J Vert Sublux Res 2008; 7:1-4.

Cohn A. Improvement in autism spectrum disorder following vertebral subluxation reduction: a case study. J Pediatr Matern & Fam Health 2011; 4:87-91.






Print Page

HPV Cancers Rising In Spite of Vaccination



A new study by the National Cancer Institute (NCI) reveals that, despite increasing uptake of human papillomavirus (HVP) vaccines, cancers linked to HPV rose in the past decade.

The report, published in the Journal of the National Cancer Institute, was co-authored by researchers from the American Cancer Society (ACS), the Centers for Disease Control and Prevention (CDC), the National Cancer Institute (NCI), and the North American Association of Central Cancer Registries (NAACCR), and found that while overall cancer death rates in the U.S. continue to decline among both men and women over the past decade, incidence rates are actually increasing for HPV-associated oral, vulva and anal cancers.


As reported by Fierce Vaccines, this finding may "irk HPV vaccine makers Merck and GlaxoSmithKline," whose vaccines have been adopted and lauded by national and global health authorities as safe and effective, 'live saving' interventions.

Obviously, if the report is correct, and by 2010 as many as 48.7 percent of girls ages 13 through 17 had received at least one dose of the HPV vaccine, and 32 percent received all three recommended doses, we should expect to find a widespread decline in HPV-associated cancers if the vaccines actually work as advertised.


While HPV-associated diseases are multifactorial in etiology, with environmental exposures, co-infections, immune dysfunction, nutritional incompatibilities, excesses and deficiencies, and stress-related physiological factors playing key roles, the vaccine industry and their governmental extensions have largely opted for reductionism in their marketing, projecting the rhetorical view that HPV is the single most important, if not the only cause of HPV-associated conditions such as anal and cervical cancer.

All the more reason why this new study is so devastating to their aggressive marketing and PR campaigns, and why the subsequent rallying cry for greater HPV vaccine coverage as the solution to the vaccine's failure -- though extremely typical -- is all the more disturbing.

HPV researcher Dr. Diane Harper on Katie Couric's controversial show dedicated to the topic, and the CDC's own admission that the HPV vaccines being used today have very limited effectiveness:

"According to the CDC's website, there are over 100 forms of HPV that have been identified thus far, with the vaccine only protecting (in theory) against four, namely, HPV types 6, 11, 16 and 18. Nor does vaccination speed the clearance of pre-existing HPV 16/18 infection, making Dr. Harper's point about the prevalence of HPV infection in those younger than 11 all the more poignant. So, how effective can a 2-4 strain vaccine possibly be even if it works 100% of the time against them?"



The answer is of course not very effective. And nowhere is this more clearly evident than in the case of African-American girls and women...


Only two months ago, a groundbreaking but virtually unknown report on the National Library of Medicine's health information portal Medline Plus, revealed a disturbing fact about the HPV vaccine, and the institutionalized 'color blindness' in biomedicine today that is having significant adverse impacts on minority populations.

Researchers from Duke University found that although African-American women are twice as likely as Caucasian women to die from cervical cancer, HPV vaccines target strains of HPV that are far less likely to infect them, and are not found in the most concerning precancerous abnormalities. 


As reported by Afro.com:

"The study examined 280 Black women and 292 White women, all carrying varying HPV strains. Some had no signs of cancer, some showed mild signs of pre-cancer and a small percentage had advanced precancerous abnormalities. In the group with the most advanced signs of pre-cancer, White participants carried strains 16, 18, 33, 39, and 59, whereas Black participants carried strains 31, 35, 45, 56, 58, 66, and 68.

Currently, two vaccines on the market target four HPV strains considered most troublesome. Gardasil, which is produced by Merck and can be administered to anyone aged 9 through 26, protects against strains 16, 18, 6, and 11. Cervarix, by GlaxoSmithKline, is available only for girls and women and targets strains 16 and 18."


Could this explain why rates of cervical cancer actually increased in African-American populations, according to the new NCI report?

When a vaccine is being used that forces the immune system of black girls or women to produce antibodies and mobilize immune defenses against HPV strains that are not contributing to the pathogenesis of the presumed 'vaccine preventable' disease, not only does this waste valuable immune resources that would be useful elsewhere, but it focuses the immune system towards a non-existent threat and away from the real one.



Obviously, vaccines that produce antibodies without antigen-antibody affinity are not only useless, but harmful. And this does not even account for the multiple, unintended, adverse effects of the other vaccine ingredients (e.g. adjuvants; biologicals) found within the shot.

Shouldn't these two studies confirm that at the very least, African-American populations should refrain from HPV vaccines until further evidence is provided that they are safe and effective? Is this not basic to the precautionary principle, especially when it comes to an unnecessary medical intervention? Shouldn't the burden of proof of safety and efficacy be upon those manufacturing, selling, regulating the product and not the exposed populations who increasingly are being told they have little to no choice in the matter?





Print Page

Marijuana Prevents The Spread of HIV



Marijuana-Like Chemicals Inhibit Human Immunodeficiency Virus (HIV) in Late-State AIDS

The overwhelming evidence of the curative powers of marijuana and cannabinoids leave little doubt that the pharmaceutical industry is behind marijuana prohibition laws. The amount of research now validating the truly remarkable nature of this healing plant is simply enormous. According to new findings published in the journal PLoS ONE, researchers have now have now discovered that marijuana-like chemicals trigger receptors on human immune cells that can directly inhibit a type of human immuno-deficiency virus (HIV) found in late-stage AIDS.


The U.S. Patent 6630507 was specifically initiated when researchers found that cannabinoids had specific antioxidant properties making them useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease and HIV dementia.



The Netherlands became the world's first country to make cannabis available as a prescription drug in pharmacies to treat cancer, HIV and multiple sclerosis patients

Medical marijuana has been typically prescribed to treat pain, debilitating weight loss and appetite suppression in patients with advanced AIDS. However, Mount Sinai School of Medicine researchers have produced the first study to reveal how the marijuana receptors found on immune cells--called cannabinoid receptors CB1 and CB2--can influence the spread of the virus.

Unfortunately, the scientists will use the research on the effects of these receptors to develop new drugs to benefit the pharmaceutical industry.
Marijuana researcher and activist Jason Mihaldas says the studies finally justify what the pro-marijuana community has always know. "Decades of anecdotal and empirical evidence are now being validated by the scientific community, but it's unfortunate they are using this research for their own selfish motives--to take marijuana from its raw medically effective form to one where it will be medically ineffective with processing agents, altering what it was designed to do...heal," proclaimed Mihaldas.

“We knew that cannabinoid drugs like marijuana can have a therapeutic effect in AIDS patients, but did not understand how they influence the spread of the virus itself,” said study author Cristina Costantino, PhD, Postdoctoral Fellow in the Department of Pharmacology and Systems Therapeutics at Mount Sinai School of Medicine. “We wanted to explore cannabinoid receptors as a target for pharmaceutical interventions that treat the symptoms of late-stage AIDS and prevent further progression of the disease without the undesirable side effects of medical marijuana.”

Nonpsychoactive cannabinoids, such as cannabidoil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention. CBD (Cannabidiol), one of the main constituents of the cannabis plant has been proven medically to relieve many diseases including the inhibition of cancer cell growth.

    The compounds of marijuana activated receptors CB1 and CB2

Recent studies have shown it to be an effective atypical anti-psychotic in treating schizophrenia. CBD also interferes with the amount of THC your brain processes, balancing the psychotropic effect of marijuana. That is precisely why the power of raw cannabis is turning heads.

HIV infects active immune cells that carry the viral receptor CD4, which makes these cells unable to fight off the infection. In order to spread, the virus requires that “resting” immune cells be activated. In advanced AIDS, HIV mutates so it can infect these resting cells, gaining entry into the cell by using a signaling receptor called CXCR4. By treating the cells with a cannabinoid agonist that triggers CB2, Dr. Costantino and the Mount Sinai team found that CB2 blocked the signaling process, and suppressed infection in resting immune cells.

The Mount Sinai team infected healthy immune cells with HIV, then treated them with a chemical that triggers CB2 called an agonist. They found that the drug reduced the infection of the remaining cells.


“Developing a drug that triggers only CB2 as an adjunctive treatment to standard antiviral medication may help alleviate the symptoms of late-stage AIDS and prevent the virus from spreading,” said Dr. Costantino. Because HIV does not use CXCR4 to enhance immune cell infection in the early stages of infection, CB2 agonists appear to be an effective antiviral drug only in late-stage disease.

As a result of this discovery, the research team led by Benjamin Chen, MD, PhD, Associate Professor of Infectious Diseases, and Lakshmi Devi, PhD, Professor of Pharmacology and Systems Therapeutics at Mount Sinai School of Medicine, plans to develop a mouse model of late-stage AIDS in order to test the efficacy of a drug that triggers CB2 in vivo.

Now that the scientific evidence is being made public, a concerted effort must be made from all nations to end marijuana-prohibition laws. Holding or possessing a plant should never be a criminal offence and the origins and source for these laws are now coming to light.







Print Page

Coconut Oil and Cannabis Capsule – A Medical Miracle?




Humans have cultivated and used the flowering tops of the female cannabis plant, known colloquially as marijuana, since history was recorded. Archaeologists in Central Asia even found over 2 pounds of cannabis in a 2,700 year-old grave of a shaman.

Written and pictorial evidence of cannabis use is scattered throughout numerous cultures indicating a wide acceptance and use of the plant for thousands of years.

   Drug Classification Halts Use

Federal prohibitions outlawing the therapeutic and recreational use of cannabis were first imposed by Congress with the Marijuana Tax Act of 1937. Later, the plant’s organic compounds (cannabinoids) were classified as a Schedule I substance under the Controlled Substances Act of 1970.

This classification puts the plant in the same pool as heroin and states that cannabis possesses “a high potential for abuse … no currently accepted medical use … [and] a lack of accepted safety for the use of the drug … under medical supervision.”



In contrast, cocaine and methamphetamine – illegal for recreational use, may be consumed under a doctors supervision and are classified as Schedule II drugs. Examples of Schedule III and IV drugs include anabolic steroids and Valium. Analgesics that contain codeine are defined by law as Schedule V drugs, the most lenient classification.

   In Support of Therapeutic Use

Federal lawmakers continue to use the dated drug classification as a means to defend criminalization of marijuana. However, there appears to be very little scientific basis for the categorization of the plant. As its prohibition has passed 75 years, researchers continue to study the therapeutic properties of cannabis.

There are over 20,000 published reviews and studies in scientific literature that pertain to the cannabis plant and its cannabinoids, almost one-third of these have been published in the last 4 years. A keyword search on PubMed Central (the US government library of peer-reviewed scientific research) shows 2,100 studies alone since 2011.

Modern culture is now catching up on what our ancestors knew, and public opinion and relaxing state legislation are leading the way for more people to use medicinal marijuana for a wide number of medical conditions. At present, marijuana for medical purposes is legal in 20 states and the District of Columbia.

While the debate continues to boil at both state and federal levels, there has been a strong and growing trend of acceptance related to the growing body of scientific evidence indicating that marijuana may indeed contain some powerful medicinal properties that we would be foolish to overlook.


Joycelyn Elders, MD, former US Surgeon General, wrote the following in a Mar. 26, 2004 article titled “Myths About Medical Marijuana,” published in the Providence Journal:

“The evidence is overwhelming that marijuana can relieve certain types of pain, nausea, vomiting and other symptoms caused by such illnesses as multiple sclerosis, cancer and AIDS — or by the harsh drugs sometimes used to treat them. And it can do so with remarkable safety. Indeed, marijuana is less toxic than many of the drugs that physicians prescribe every day.”

Ray Cavanaugh, PhD, National Director of the American Alliance for Medical Cannabis (AAMC), wrote the following in a 2002 article titled “The Plight of the Chronically Ill,” posted on the AAMC website:


“Many of the chronically ill have successfully sought relief with the use of medical cannabis, an age-old remedy that now shows real scientific efficacy. Hundreds of thousands of the sick have replaced disabling narcotics and other psychotropic medications with nontoxic and benign cannabis. The anecdotal evidence is overwhelming. Folks with spinal injuries able to give up their walkers, AIDS patients able to gain weight and keep their medications down, cancer patients finding relief from the terrible nausea of chemotherapy, chronic pain patients once again functional with their consciousness restored from narcotic lethargy, and folks once disabled from crippling psychiatric disorders and addictions, returned to sanity and society with the assistance of a nontoxic herb with remarkable healing powers.”



The American Nurses Association (ANA) wrote the following in its Mar. 19, 2004 “Position Statement: Providing Patients Safe Access to Therapeutic Marijuana/Cannabis,” posted on the ANA website:


“The American Nurses Association (ANA) recognizes that patients should have safe access to therapeutic marijuana/cannabis. Cannabis or marijuana has been used medicinally for centuries. It has been shown to be effective in treating a wide range of symptoms and conditions.”

Researchers at the University of California Center for Medicinal Cannabis Research announced findings from a number of randomized, placebo controlled clinical trials on the medical utility of inhaled cannabis in 2010.

The studies used the FDA ‘gold standard’ clinical trial design and reported that marijuana should be the “first line of treatment” for patients suffering from neuropathy and other serious illnesses.

Neuropathy is a type of pain associated with diabetes, cancer, spinal cord injuries, HIV/AIDS and other debilitating conditions. The trials indicated that marijuana controlled pain as good or better than available medications.

Scientists continue to study the effectiveness of cannabinoids all over the world. In Germany there have been over 37 controlled studies, with over 2,500 subjects, assessing the safety and efficacy of marijuana, since 2005. In contrast, most FDA-approved drugs go through far fewer trials with less subjects but are approved for use.

The research on cannabis has shifted from studying its ability to alleviate symptoms of disease such as nausea associated with chemotherapy to its potential role in modifying disease. Medical marijuana has been shown to slow the onset of Alzheimers disease and moderate autoimmune disorders including multiple sclerosis, inflammatory bowel disease and rheumatoid arthritis.


   Cannabis and Coconut Oil

Medical marijuana capsules infused in coconut oil are an alternative way to therapeutically use cannabis without having to inhale it through smoking. Infusing cannabis into coconut oil also allows for easy entry into the liver where it can be rapidly processed.

Coconut oil is used because of its high amount of essential fatty acids which makes it a good binding agent for the cannabinoids. Not to mention its amazing health properties. Half of the fat in coconut oil is comprised of a fat that is not frequently found in nature, lauric acid.


Lauric acid has been called a “miracle” ingredient due to its health promoting capabilities and is present in a mother’s milk. In fact, it can be found in only three dietary sources—small amounts in butterfat and larger amounts in palm kernel and coconut oil.


In the body, lauric acid is converted to monolaurin, which is a potent antiviral, antibacterial and antiprotozoal substance. Because monolaurin is a monoglyceride, it can destroy lipid-coated viruses including measles, influenza, HIV, herpes and a number of pathogenic bacteria.

   Testimony – A Success Story

While many remain suspicious of the therapeutic benefits of cannabis, Stan and Barb Rutner are convinced of its efficacy. This couple has stood in the face of cancer a number of times and survived to learn from their experiences.

Barb had two bouts of breast cancer and Stan was diagnosed 20 years ago with non-Hodgkin lymphoma which, after treatment, disappeared. However, in 2011, it returned. Cancerous nodes in his lungs were diagnosed and later he was told that the cancer was in his brain. The outlook was grim indeed.

As he went through the harsh treatment of chemotherapy and radiation, Stan and his family wanted to find a natural solution that would help improve his quality of life and even prolong it. Hearing that cannabis was effective in helping with the pain and other effects of chemotherapy for cancer patients they were more than open to give it a try. According to Stan and Barb, medical cannabis was the golden ticket.

The Rutners daughter, Corinne and her husband did some research and it was decided that daytime cannabis capsule infused in coconut oil would be a good choice. After two weeks of taking the capsule, Stan was able to give up his oxygen tank that he was tied to around the clock. He began to gain weight, sleep better and get stronger overall. After several months, a brain scan revealed that Stan was completely cancer free.

The Rutners are convinced that cannabis works as an anti-cancer medicine. According to John, the Rutners son-in-law, “There is no doubt in my mind that cannabis pulled my father-in-law out of the wasting stages of cancer and enabled him to gain strength and in turn fight this horrible cell malfunction with success. While many would say that the chemo and radiation could have played apart, he would never have lived long enough to find out without cannabis oil.”







Print Page
Related Posts Plugin for WordPress, Blogger...